Page last updated: 2024-11-02

pindolol and Edema

pindolol has been researched along with Edema in 1 studies

Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.

Edema: Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.

Research Excerpts

ExcerptRelevanceReference
"The long-term efficacy of isradipine, a new dihydropyridine calcium antagonist with marked vascular selectivity, was evaluated in 17 patients with essential hypertension."5.06The long-term effect of isradipine in pindolol-treated patients. ( Andrén, L; Dahlöf, B; Eggertsen, R; Hansson, L; Jern, S; Svensson, A, 1987)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dahlöf, B1
Andrén, L1
Eggertsen, R1
Jern, S1
Svensson, A1
Hansson, L1

Trials

1 trial available for pindolol and Edema

ArticleYear
The long-term effect of isradipine in pindolol-treated patients.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1987, Volume: 5, Issue:5

    Topics: Aged; Body Weight; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Edema;

1987